Neonc Technologies Holdings(NTHI)今日正式披露了其2026年第二季度的财务表现。与此同时,该公司还郑重确认,其备受瞩目的Neo100二期a阶段临床试验的顶线数据,定于8月12日揭晓。
Neonc Technologies Holdings(NTHI)今日正式披露了其2026年第二季度的财务表现。与此同时,该公司还郑重确认,其备受瞩目的Neo100二期a阶段临床试验的顶线数据,定于8月12日揭晓。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.